{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:06:16Z","timestamp":1789059976949,"version":"build-2803163510"},"reference-count":19,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University Duisburg-Essen"},{"id":[{"id":"https:\/\/ror.org\/04mz5ra38","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Background: Vasoplegia after heart failure surgery has been associated with increased morbidity and mortality. The aim of this study was to evaluate the incidence and impact of postoperative vasoplegia in patients undergoing durable continuous flow left ventricular assist device implantation (cfLVAD). Methods: All patients who underwent cfLVAD implantation were included in this analysis. Vasoplegia was defined as the need for norepinephrine \u22650.2 \u03bcg\/kgBW\/min and\/or any vasopressin dose for \u226512 h starting within 72 h postoperatively without bleeding\/pericardial tamponade requiring surgical revision. Endpoints included the incidence of vasoplegia and 30- and 90-day mortality. Cox proportional hazard model was used to assess the association between vasoplegia and mortality. Multivariate logistic regression analysis was performed to identify predictors of vasoplegia. Results: Between 08\/2010 and 12\/2023, 307 consecutive patients underwent durable cfLVAD implantation. Mean age was 58 \u00b1 11 years. Of the patients, 94% were operated with cardiopulmonary bypass and in 71% intraoperative hemoadsorption was applied. The incidence of vasoplegia was 23%. Vasoplegia was significantly associated with increased short-term mortality compared to non-vasoplegic patients (HR: CI: p &lt; 0.001). Multivariate regression analysis identified preoperative invasive ventilation and preoperative vasopressor support as strong risk factors for postoperative vasoplegia, while intraoperative hemoadsorption reduced this risk. Conclusion: Vasoplegia after durable cfLVAD implantation is a common and serious complication associated with increased short-term mortality. Preoperative mechanical ventilation and vasopressor support are risk factors for developing postoperative vasoplegia. Intraoperative hemoadsorption appears to reduce the risk of vasoplegia after durable cfLVAD implantation.<\/jats:p>","DOI":"10.3390\/jcdd13090456","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:54:19Z","timestamp":1789055659000},"page":"456","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, Predictors and Outcome of Vasoplegia After Left Ventricular Assist Device Implantation"],"prefix":"10.3390","volume":"13","author":[{"given":"Zaki","family":"Haidari","sequence":"first","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Centre, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Iskandar","family":"Turaev","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Centre, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Ender","family":"Demircioglu","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Centre, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Stephan","family":"Knipp","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Centre, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: A meta-analysis","volume":"28","author":"Dayan","year":"2019","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"Lambden","year":"2018","journal-title":"Crit. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2044.2006.04779.x","article-title":"Association between vasopressor dependence and early outcome in patients after cardiac surgery","volume":"61","author":"Weis","year":"2006","journal-title":"Anaesthesia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival After Shock Requiring High-Dose Vasopressor Therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early On\u2013Cardiopulmonary Bypass Hypotension and Other Factors Associated with Vasoplegic Syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ni Hici, T., Boardman, H.M., Baig, K., Stafford, J.L., Cernei, C., Bodger, O., and Westaby, S. (2020). Mechanical assist devices for acute cardiogenic shock. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD013002.pub2"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.healun.2016.01.1225","article-title":"Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis","volume":"35","author":"Houston","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"ref_10","first-page":"1787","article-title":"ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_12","first-page":"532","article-title":"Incidence and predictors of vasoplegia after heart failure surgery","volume":"51","author":"Palmen","year":"2016","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tecson, K.M., Lima, B., Lee, A.Y., Raza, F.S., Ching, G., Lee, C., Felius, J., Baxter, R.D., Still, S., and Collier, J.D.G. (2018). Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation. J. Am. Heart Assoc., 7.","DOI":"10.1161\/JAHA.117.008377"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"De Waal, E.E., Van Zaane, B., Van Der Schoot, M.M., Huisman, A., Ramjankhan, F., Van Klei, W.A., and Marczin, N. (2018). Vasoplegia after implantation of a continuous flow left ventricular assist device: Incidence, outcomes and predictors. BMC Anesthesiol., 18.","DOI":"10.1186\/s12871-018-0645-y"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Radley, G., Pieper, I.L., Ali, S., Bhatti, F., and Thornton, C.A. (2018). The Inflammatory Response to Ventricular Assist Devices. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02651"},{"key":"ref_16","first-page":"348","article-title":"Longitudinal Assessment of Inflammation in Recipients of Continuous-Flow Left Ventricular Assist Devices","volume":"31","author":"Jacobs","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Caruso, R., Botta, L., Verde, A., Milazzo, F., Vecchi, I., Trivella, M.G., Martinelli, L., Paino, R., Frigerio, M., and Parodi, O. (2014). Relationship between Pre-Implant Interleukin-6 Levels, Inflammatory Response, and Early Outcome in Patients Supported by Left Ventricular Assist Device: A Prospective Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090802"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00002480-200105000-00023","article-title":"Inflammatory Response after Implantation of a Left Ventricular Assist Device: Comparison between the Axial Flow MicroMed DeBakey VAD and the Pulsatile Novacor Device","volume":"47","author":"Loebe","year":"2001","journal-title":"Asaio J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0003-4975(01)03510-X","article-title":"Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: Role of inflammatory response and hepatic microcirculation","volume":"73","author":"Masai","year":"2002","journal-title":"Ann. Thorac. Surg."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/9\/456\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:08:26Z","timestamp":1789056506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/9\/456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcdd13090456"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13090456","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}